Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation of the Safety and Pharmacokinetics of a Single Dose of Linzagolix in Female Subjects With Normal and Impaired Hepatic Function

NCT03962049 is registered in ClinicalTrials.gov with ObsEva SA as lead sponsor.

NCT NCT03962049
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03962049 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation of the Safety and Pharmacokinetics of a Single Dose of Linzagolix in Female Subjects With Normal and Impaired Hepatic Function
Lead sponsor
ObsEva SA
Phase
Phase 1
Overall status
Completed
Start date
May 15, 2019
Completion date
November 1, 2019
Enrollment
24 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

healthy participants, hepatic impairment